Pharmaceutical

Tempus AI expands oncology collaboration with Takeda

Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development.

Sep 28, 2024 - 04:00
Tempus AI expands oncology collaboration with Takeda
Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development.
Read the original article

Tags:

Previous Article

API Chemical Contract Manufacturing Companies for the Pharmaceutical Industry

Next Article

Phare Bio receives ARPA-H funds for AI drug discovery platform

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The Genomic Medicine Revolution: Multi-Modality Approaches in Advanced Therapies 

The Genomic Medicine Revolution: Multi-Modality Approac...

Aug 17, 2024

Travere Therapeutics drug, approved for one rare and deadly kidney disease, fails in study of another

Travere Therapeutics drug, approved for one rare and de...

May 1, 2023

AGC Biologics and the Jikei University partner for IPF project

AGC Biologics and the Jikei University partner for IPF ...

Apr 4, 2023